Push Admin

Philippines eyes Sinovac trial as early as November

Article (news)

Neil Jerome Morales and Karen Lema, Reuters

<div class="embed-wrap"><figure data-feedback="fb:likes,fb:comments"><img src="https://sa.kapamilya.com/absnews/abscbnnews/media/2020/reuters/09/27/vaccine.jpg"/><figcaption>A worker performs a quality check in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus disease (COVID-19) vaccine, during a government-organized media tour in Beijing, China, September 24, 2020. <em>Thomas Peter, Reuters</em></figcaption></figure></div><p>MANILA - Sinovac Biotech may start late-stage trials of its coronavirus vaccine in the Philippines as early as next month, its food and drug agency chief said on Thursday, after it hurdled the initial stage of the country&#x27;s screening process.</p><p>The Food and Drug Administration (FDA) expects to receive the Chinese drug maker&#x27;s formal application for phase three clinical trials within two weeks and regulators will make a decision after their evaluation, FDA head Rolando Enrique Domingo said.</p><p>Domingo told reporters a November trial start was &quot;possible&quot;.<br/>Philippine President Rodrigo Duterte repeated on Wednesday that he preferred that his country source its COVID-19 vaccines from either China or Russia. </p><p>He also said he wanted the entire population vaccinated and has previously said he would not reopen schools until a vaccine was available.</p><p>A Sinovac spokesman confirmed that materials had been provided to the Philippines in the hope of starting Phase 3 trials, but gave no timeframe.</p><p>Jaime Montoya, a member of an expert panel screening applications for clinical trials and medications, told Reuters a technical evaluation of Sinovac had been completed and results already submitted to an ethics board for review.</p><ul class="op-related-articles">	<li><a href="https://news.abs-cbn.com/news/10/14/20/nakahanap-na-ako-ng-pera-duterte-says-funds-available-for-covid-19-vaccine">&#x27;Nakahanap na ako ng pera&#x27;: Duterte says funds available for COVID-19 vaccine</a></li>	<li><a href="https://news.abs-cbn.com/news/07/31/20/duterte-leaves-distribution-of-covid-19-vaccines-to-military">Duterte leaves distribution of COVID-19 vaccines to military</a></li></ul><p>The Philippines is also evaluating COVID-19 vaccines of Russia&#x27;s Gamaleya Research Institute and Johnson &amp; Johnson&#x27;s Janssen for late-stage trials and is talking to U.S. drugmaker Pfizer Inc and Moderna Inc as potential suppliers.</p><p>The Southeast Asian nation has 346,536 confirmed COVID-19, the highest in the region, and 6,449 deaths.</p><figure class="op-interactive"><iframe height="315" src="https://www.youtube.com/embed/CEn8ShGYGFo?enablejsapi=1" width="560"></iframe></figure><div class="iwantbar">Watch more in <a href="//www.iwantv.com.ph/">iWantv</a> or <a href="//tfc.tv/">TFC.tv</a></div>

<p>Sinovac Biotech may start late-stage trials of its coronavirus vaccine in the Philippines as early as next month, its food and drug agency chief said on Thursday, after it hurdled the initial stage of the country's screening process.</p>

Sinovac Biotech may start late-stage trials of its coronavirus vaccine in the Philippines as early as next month, its food and drug agency chief said on Thursday, after it hurdled the initial stage of the country's screening process.

Philippines eyes Sinovac trial as early as November

News

Entertainment

Lifestyle

Sports

Metro.Style

More

Traffic

Manila

Horoscope

News

Philippines eyes Sinovac trial as early as November

Neil Jerome Morales and Karen Lema,

Reuters

Published Oct 15, 2020 04:26 PM PHT

|

Updated Oct 15, 2020 05:22 PM PHT

Read More:

Sinovac

Sinovac vaccine

China vaccine

Sinovac Philippine trial

coronavirus vaccine

Food and Drug administration

FDA

November vaccine trial

COVID-19 pandemic

coronavirus update

ABS-CBN is the leading media and entertainment company in the Philippines, offering quality content across TV, radio, digital, and film. Committed to public service and promoting Filipino values, ABS-CBN continues to inspire and connect audiences worldwide.

Corporate

Investors

Governance

International Distribution

Corporate

Governance

Investors

International Distribution

NPC Seal of Registration

Privacy Policy

AI Policy

Terms of Service

Advertise with Us

© 2025 ABS-CBN Corporation. All Rights Reserved.

NPC Seal of Registration

Privacy Policy

Terms of Service

AI Policy

Advertise with Us

© 2025 ABS-CBN Corporation. All Rights Reserved.

NPC Seal of Registration

Privacy Policy

Terms of Service

AI Policy

Advertise with Us

© 2025 ABS-CBN Corporation. All Rights Reserved.